The protein p17 signaling pathways in cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Heese, Klaus | - |
dc.date.accessioned | 2022-07-16T07:03:15Z | - |
dc.date.available | 2022-07-16T07:03:15Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2013-12 | - |
dc.identifier.issn | 1010-4283 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161268 | - |
dc.description.abstract | P17 is a novel neuronal protein expressed under physiological conditions only at very low levels in other tissues. Accumulating data indicate its crucial involvement in tumorigenic effects. Using molecular, cellular, and biocomputational methods, the current study unraveled p17 mode of action. Data indicate that mitochondria-associated p17 interacts with the proteins TMEM115, YPEL3, ERP44, CDK5RAP, and NNAT. Moreover, p17 drives the cell cycle into the G0/G1 phase and enhances survival of proliferating cells. Interference with p17 activities thus might become a novel option to influence also the tumor suppressor protein p53 signaling pathways for the treatment of tumors. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | The protein p17 signaling pathways in cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Heese, Klaus | - |
dc.identifier.doi | 10.1007/s13277-013-0999-1 | - |
dc.identifier.scopusid | 2-s2.0-84891491280 | - |
dc.identifier.wosid | 000328292100098 | - |
dc.identifier.bibliographicCitation | TUMOR BIOLOGY, v.34, no.6, pp.4081 - 4087 | - |
dc.relation.isPartOf | TUMOR BIOLOGY | - |
dc.citation.title | TUMOR BIOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 4081 | - |
dc.citation.endPage | 4087 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | URACIL-DNA GLYCOSYLASE | - |
dc.subject.keywordPlus | BASE EXCISION-REPAIR | - |
dc.subject.keywordPlus | WIP1 PHOSPHATASE | - |
dc.subject.keywordPlus | P53 | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | YPEL3 | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | INSIGHTS | - |
dc.subject.keywordPlus | UGENE | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Oncology | - |
dc.subject.keywordAuthor | FAM72A | - |
dc.subject.keywordAuthor | Ugene | - |
dc.subject.keywordAuthor | p53 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.